Michael Dore
11Patents
4h-index
25Co-inventors
56Inventor score
Filing activity: Jan 16, 2015 → Apr 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10077276B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 14 | Active |
| US9815813B2 | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 13 | Active |
| US10301278B2 | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 8 | Active |
| US10336774B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 6 | Active |
| US10968235B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 3 | Active |
| US12060353B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | Chemistry; Metallurgy | 1 | Active |
| US10975080B2 | Compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 1 | Active |
| US9938295B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | General | 0 | Revoked |
| US11952386B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 0 | Active |
| US12209098B2 | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 0 | Active |
| US12139488B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.